Exocrine pancreatic involvement in primitive syndrome of Sjogren
2003-01-01 Candelli, M; Manganelli, C; Celestino, Ec; Turco, S; Pignataro, G; Zocco, Ma; Armuzzi, A; Scullica, L; Gasbarrini, G; Gasbarrini, A
Haplotypic analysis of heat shock protein 70 (HSP70) single nucleotide polymorphisms (SNPs) in susceptibility and phenotype of inflammatory bowel disease (IBD)
2002-01-01 Armuzzi, A; Ahmad, T; Marshall, S; Mulcahy-Hawes, K; Large, O; Crawshaw, J; Ling, K; De Silva, Ap; Bunce, M; Welsh, K; Jewell, D
Fecal calprotectini in first degree relatives of patients with ulcerative colitis
2007-01-01 Montalto, M; Curigliano, V; Santoro, L; Armuzzi, A; Cammarota, G; Covino, M; D'Onofrio, F; Gallo, A; Gasbarrini, A; Gasbarrini, G
High oxygen free radicals generation in gastric mucosa infected by H-pylori cytotoxic strains
2000-01-01 Danese, S; Candelli, M; Cremonini, F; Armuzzi, A; Ojetti, V; Pastorelli, A; Zannoni, G; Camardese, G; Padalino, C; Gasbarrini, Gb; De Sole, P; Gasbarrini, A
H-pylori poliantibiotic resistant strains in dyspeptic patients not eradicated by two consecutive triple eradication regimens
1999-01-01 Gasbarrini, A; Branca, G; Ojetti, V; Candeloro, L; De Vitis, I; Pastorelli, A; Franceschi, F; Armuzzi, A; Torre, Es; Candelli, M; Canducci, F; Anti, M
Nonalcoholic-Steatohepatitis (NASH) and hepatic mitochondrial beta-oxidation
2003-01-01 Miele, L; Grieco, A; Armuzzi, A; Candelli, M; Zocco, Ma; Forgione, A; Alfei, B; Rapaccini, Gl; Gasbarrini, G; Gasbarrini, A
HELICOBACTER-PYLORI GASTRITIS WITH CYTOTOXIN ASSOCIATED PROTEIN ANTIBODIES (CAGA) - A COMPUTER-AIDED EVALUATION OF INFLAMMATORY CELL INFILTRATION IN THE LAMINA PROPRIA, ATROPHIC GASTRITIS AND ACQUIRED MALT
1995-01-01 Baldini, L; Bonvicini, F; Pretolani, S; Figura, N; Epifanio, G; Capriati, G; Armuzzi, A; Fasanella, C; Cogliandro, L; Pasini, P; Bernardi, M; Gasbarrini, G
Behcet or Crohn disease? Combination HLA-B*51 and CARD15 molecular typing may help decide
2002-01-01 Ahmad, T; Wallace, G; James, T; Bunce, M; Mulcahy-Hawes, K; Armuzzi, A; Fortune, F; Stanford, M; Welsh, K; Marshall, S; Jewell, D
EFFECT OF ANTI-HELICOBACTER-PYLORI THERAPY ON INFLAMMATORY CELL INFILTRATION AND ACQUIRED MALT IN GASTRIC-MUCOSA - A MORPHOMETRIC STUDY BY MEANS OF COMPUTER-ASSISTED IMAGE-ANALYSIS
1995-01-01 Armuzzi, A; Cammarota, G; Tursi, A; Montalto, M; Addolorato, G; Certo, M; Baldini, L; Fedeli, G; Pretolani, S; Bonvicini, F; Gasbarrini, G
Recurrent oral ulceration (ROU) in inflammatory bowel disease (IBD): The clinical hallmark of a molecularly defined IBD/Behcet's (BD) overlap group
2002-01-01 Ahmad, T; Mulcahy-Hawes, K; Bunce, M; Armuzzi, A; Welsh, K; Marshall, S; Jewell, D
The intercellular adhesion molecule-1 polymorphisms in IBD
2002-01-01 Li, Jh; Yang, Xs; Cullen, S; Lin, Kl; Armuzzi, A; Ahmad, T; Neville, Mj; Walton, R; Jewell, D
INFLIXIMAB IN STEROID-DEPENDENT ULCERATIVE COLITIS
2011-01-01 Armuzzi, A; Pugliese, D; Marzo, M; Felice, C; Andrisani, G; De Vincentis, F; Mocci, G; De Vitis, I; Papa, A; Rapaccini, Gl; Guidi, L
Infliximab in Steroid-Dependent Ulcerative Colitis
2011-01-01 Armuzzi, A; Pugliese, D; Marzo, M; Felice, C; Andrisani, G; Vitale, G; Mocci, G; De Vitis, I; Papa, A; Rapaccini, Gl; Guidi, L
The 5q31/IBD5 risk haplotype determines perianal phenotype in Crohn's disease
2002-01-01 Armuzzi, A; Ahmad, T; De Silva, Ap; Ling, K; Cullen, S; Van Heel, D; Jewell, D
Quantification of Microvascular Activation in Ileal Crohn's Disease By Software Elaboration Data Applied to CEUS: Correlation with Biological Activity Indexes
2009-01-01 De Franco, A; Di Veronica, A; Guidi, L; Armuzzi, A; De Vitis, I; Papa, A; Marzo, M; Felice, C; Bock, E; Bonomo, L
PREVALENCE AND NATURAL HISTORY OF HEPATITIS B AND C VIRUS INFECTION IN A LARGE COHORT OF PATIENTS AFFECTED BY INFLAMMATORY BOWEL DISEASE IN TREATMENT WITH ANTI-TNF-A AGENTS
2011-01-01 Papa, A; Armuzzi, A; Marzo, M; Felice, C; Mocci, G; Andrisani, G; Pugliese, D; Scaldaferri, F; De Vitis, I; Gasbarrini, A; Rapaccini, G; Covino, M; Guidi, L
Influence of the IBD5/5q31 cytokine cluster haplotype an celiac disease genetic susceptibility
2002-01-01 Van Heel, D; Mcgovern, Dp; Negoro, K; Armuzzi, A; Segal, S; Ahmed, T; Barnardo, M; Anderson, Rp; Jewell, D
Mono, dual and triple moxifloxacin-based regimens for Helicobacter pylori eradication
2001-01-01 Di Caro, S; Ojetti, V; Zocco, Ma; Cremonini, F; Bartolozzi, F; Armuzzi, A; Gabrielli, M; Candelli, M; Sanz-Torre, E; Nista, E; Lupascu, A; Cammarota, G; Gasbarrini, G; Gasbarrini, A
Antibiotic resistance of H-pylori strains obtained by dyspeptic patients not eradicated by two consecutive eradication regimens
1998-01-01 Gasbarrini, A; Branca, G; Ojetti, V; Candeloro, L; De Vitis, I; Franceschi, E; Torre, Es; Candelli, M; Armuzzi, A; Pola, R; Anti, M; Pola, P; Fadda, G; Gasbarrini, G
Fecal calprotectin in Inflammatory Bowel Disease treated with anti-TNF agents
2009-01-01 Marzo, M; Armuzzi, A; Felice, C; Forni, F; Papa, A; De Vitis, I; Guidi, L
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Exocrine pancreatic involvement in primitive syndrome of Sjogren | 1-gen-2003 | Candelli, M; Manganelli, C; Celestino, Ec; Turco, S; Pignataro, G; Zocco, Ma; Armuzzi, A; Scullica, L; Gasbarrini, G; Gasbarrini, A | |
| Haplotypic analysis of heat shock protein 70 (HSP70) single nucleotide polymorphisms (SNPs) in susceptibility and phenotype of inflammatory bowel disease (IBD) | 1-gen-2002 | Armuzzi, A; Ahmad, T; Marshall, S; Mulcahy-Hawes, K; Large, O; Crawshaw, J; Ling, K; De Silva, Ap; Bunce, M; Welsh, K; Jewell, D | |
| Fecal calprotectini in first degree relatives of patients with ulcerative colitis | 1-gen-2007 | Montalto, M; Curigliano, V; Santoro, L; Armuzzi, A; Cammarota, G; Covino, M; D'Onofrio, F; Gallo, A; Gasbarrini, A; Gasbarrini, G | |
| High oxygen free radicals generation in gastric mucosa infected by H-pylori cytotoxic strains | 1-gen-2000 | Danese, S; Candelli, M; Cremonini, F; Armuzzi, A; Ojetti, V; Pastorelli, A; Zannoni, G; Camardese, G; Padalino, C; Gasbarrini, Gb; De Sole, P; Gasbarrini, A | |
| H-pylori poliantibiotic resistant strains in dyspeptic patients not eradicated by two consecutive triple eradication regimens | 1-gen-1999 | Gasbarrini, A; Branca, G; Ojetti, V; Candeloro, L; De Vitis, I; Pastorelli, A; Franceschi, F; Armuzzi, A; Torre, Es; Candelli, M; Canducci, F; Anti, M | |
| Nonalcoholic-Steatohepatitis (NASH) and hepatic mitochondrial beta-oxidation | 1-gen-2003 | Miele, L; Grieco, A; Armuzzi, A; Candelli, M; Zocco, Ma; Forgione, A; Alfei, B; Rapaccini, Gl; Gasbarrini, G; Gasbarrini, A | |
| HELICOBACTER-PYLORI GASTRITIS WITH CYTOTOXIN ASSOCIATED PROTEIN ANTIBODIES (CAGA) - A COMPUTER-AIDED EVALUATION OF INFLAMMATORY CELL INFILTRATION IN THE LAMINA PROPRIA, ATROPHIC GASTRITIS AND ACQUIRED MALT | 1-gen-1995 | Baldini, L; Bonvicini, F; Pretolani, S; Figura, N; Epifanio, G; Capriati, G; Armuzzi, A; Fasanella, C; Cogliandro, L; Pasini, P; Bernardi, M; Gasbarrini, G | |
| Behcet or Crohn disease? Combination HLA-B*51 and CARD15 molecular typing may help decide | 1-gen-2002 | Ahmad, T; Wallace, G; James, T; Bunce, M; Mulcahy-Hawes, K; Armuzzi, A; Fortune, F; Stanford, M; Welsh, K; Marshall, S; Jewell, D | |
| EFFECT OF ANTI-HELICOBACTER-PYLORI THERAPY ON INFLAMMATORY CELL INFILTRATION AND ACQUIRED MALT IN GASTRIC-MUCOSA - A MORPHOMETRIC STUDY BY MEANS OF COMPUTER-ASSISTED IMAGE-ANALYSIS | 1-gen-1995 | Armuzzi, A; Cammarota, G; Tursi, A; Montalto, M; Addolorato, G; Certo, M; Baldini, L; Fedeli, G; Pretolani, S; Bonvicini, F; Gasbarrini, G | |
| Recurrent oral ulceration (ROU) in inflammatory bowel disease (IBD): The clinical hallmark of a molecularly defined IBD/Behcet's (BD) overlap group | 1-gen-2002 | Ahmad, T; Mulcahy-Hawes, K; Bunce, M; Armuzzi, A; Welsh, K; Marshall, S; Jewell, D | |
| The intercellular adhesion molecule-1 polymorphisms in IBD | 1-gen-2002 | Li, Jh; Yang, Xs; Cullen, S; Lin, Kl; Armuzzi, A; Ahmad, T; Neville, Mj; Walton, R; Jewell, D | |
| INFLIXIMAB IN STEROID-DEPENDENT ULCERATIVE COLITIS | 1-gen-2011 | Armuzzi, A; Pugliese, D; Marzo, M; Felice, C; Andrisani, G; De Vincentis, F; Mocci, G; De Vitis, I; Papa, A; Rapaccini, Gl; Guidi, L | |
| Infliximab in Steroid-Dependent Ulcerative Colitis | 1-gen-2011 | Armuzzi, A; Pugliese, D; Marzo, M; Felice, C; Andrisani, G; Vitale, G; Mocci, G; De Vitis, I; Papa, A; Rapaccini, Gl; Guidi, L | |
| The 5q31/IBD5 risk haplotype determines perianal phenotype in Crohn's disease | 1-gen-2002 | Armuzzi, A; Ahmad, T; De Silva, Ap; Ling, K; Cullen, S; Van Heel, D; Jewell, D | |
| Quantification of Microvascular Activation in Ileal Crohn's Disease By Software Elaboration Data Applied to CEUS: Correlation with Biological Activity Indexes | 1-gen-2009 | De Franco, A; Di Veronica, A; Guidi, L; Armuzzi, A; De Vitis, I; Papa, A; Marzo, M; Felice, C; Bock, E; Bonomo, L | |
| PREVALENCE AND NATURAL HISTORY OF HEPATITIS B AND C VIRUS INFECTION IN A LARGE COHORT OF PATIENTS AFFECTED BY INFLAMMATORY BOWEL DISEASE IN TREATMENT WITH ANTI-TNF-A AGENTS | 1-gen-2011 | Papa, A; Armuzzi, A; Marzo, M; Felice, C; Mocci, G; Andrisani, G; Pugliese, D; Scaldaferri, F; De Vitis, I; Gasbarrini, A; Rapaccini, G; Covino, M; Guidi, L | |
| Influence of the IBD5/5q31 cytokine cluster haplotype an celiac disease genetic susceptibility | 1-gen-2002 | Van Heel, D; Mcgovern, Dp; Negoro, K; Armuzzi, A; Segal, S; Ahmed, T; Barnardo, M; Anderson, Rp; Jewell, D | |
| Mono, dual and triple moxifloxacin-based regimens for Helicobacter pylori eradication | 1-gen-2001 | Di Caro, S; Ojetti, V; Zocco, Ma; Cremonini, F; Bartolozzi, F; Armuzzi, A; Gabrielli, M; Candelli, M; Sanz-Torre, E; Nista, E; Lupascu, A; Cammarota, G; Gasbarrini, G; Gasbarrini, A | |
| Antibiotic resistance of H-pylori strains obtained by dyspeptic patients not eradicated by two consecutive eradication regimens | 1-gen-1998 | Gasbarrini, A; Branca, G; Ojetti, V; Candeloro, L; De Vitis, I; Franceschi, E; Torre, Es; Candelli, M; Armuzzi, A; Pola, R; Anti, M; Pola, P; Fadda, G; Gasbarrini, G | |
| Fecal calprotectin in Inflammatory Bowel Disease treated with anti-TNF agents | 1-gen-2009 | Marzo, M; Armuzzi, A; Felice, C; Forni, F; Papa, A; De Vitis, I; Guidi, L |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista2157
Data di pubblicazione
- 2020 - 2025111
- 2010 - 20191343
- 2000 - 2009591
- 1990 - 1999111
- 1988 - 19891
Editore
- Nature Publishing Group4
- s.n4
- ICRS3
- Blackwell1
Rivista
- EUROPEAN UROLOGY. SUPPLEMENTS124
- GASTROENTEROLOGY123
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...120
- THE JOURNAL OF UROLOGY111
- DIGESTIVE AND LIVER DISEASE100
- THE JOURNAL OF NUCLEAR MEDICINE80
- ANNALS OF THE RHEUMATIC DISEASES69
- RADIOTHERAPY AND ONCOLOGY59
- ANNALS OF ONCOLOGY57
- JOURNAL OF CLINICAL ONCOLOGY45
Keyword
- Myelodysplastic syndrome8
- Survival4
- biomimetic3
- Mitochondrial ferritin3
- osteochondral3
- Prognosis3
- scaffold3
- Sideroblastic anemia3
- viscosupplementation3
- COLONOSCOPIC SURVEILLANCE2
Lingua
- eng798
- ita24
- und6
Accesso al fulltext
- no fulltext2104
- reserved51
- open2